- Conditions
- Gulf War Syndrome
- Interventions
- N-Acetyl Cysteine, Placebo
- Drug
- Lead sponsor
- Nova Southeastern University
- Other
- Eligibility
- 47 Years to 70 Years
- Enrollment
- 170 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 7
- States / cities
- Palo Alto, California • Fort Lauderdale, Florida • Boston, Massachusetts + 4 more
Source: ClinicalTrials.gov public record
Updated Jul 7, 2025 · Synced May 21, 2026, 7:59 PM EDT